Illumina's acquisition of Somalogic is a clear IP play
Illumina announced on 23 June 2025 that it will acquire SomaLogic from Standard BioTools, for US$350 million cash plus up to US$75 million in performance-based payments, reinforcing its multiomics roadmap by embedding high-plex proteomics into its sequencing operations. The transaction, expected to close in the first half of